2D-DIGE analysis: platelet proteins differentially regulated when comparing basal (unstimulated) and rhodocytin-stimulated platelets
Function . | Protein . | Uniprot . | Fold change . | Spot . |
---|---|---|---|---|
Cytoskeletal | Actin, cytoplasmic 1 or 2 | ACTB_HUMAN OR ACTG_HUMAN | 3.00* | 1972 |
α-centractin | ACTZ_HUMAN | 1.80* | 1105 | |
β-centractin | ACTY_HUMAN | 2.80* | 1099 | |
Caldesmon | CALD1_HUMAN | −1.60* | 753 | |
Cofilin-1 | COF1_HUMAN | −2.40* | 1969 | |
COF1_HUMAN | −2.00* | 1856 | ||
COF1_HUMAN | −2.00* | 1828 | ||
Coronin-1A | COR1A_HUMAN | −1.60 | 886 | |
Coronin-1B | COR1B_HUMAN | −1.60 | 886 | |
COR1B_HUMAN | −1.60* | 753 | ||
COR1B_HUMAN | −1.80* | 750 | ||
Dematin | DEMA_HUMAN | −2.00* | 1973 | |
Destrin | DEST_HUMAN | −1.90* | 1887 | |
Fibrinogen γ chain | FIBG_HUMAN | 1.70 | 1257 | |
Heat shock 70-kDa protein 1A/1B or 1 like | HSP71_HUMAN OR HS71L_HUMAN | −1.80* | 750 | |
Heat shock protein β-1 | HSPB1_HUMAN | 1.80 | 1674 | |
HSPB1_HUMAN | −4.10* | 1624 | ||
HSPB1_HUMAN | −2.50* | 1623 | ||
HSPB1_HUMAN | 1.80 | 1580 | ||
Microtubule-associated protein RP/EB family member 2 | MARE2_HUMAN | −1.70* | 1981 | |
Myosin regulatory light chain 12A or 12B | ML12A_HUMAN OR ML12B_HUMAN | 3.30* | 1802 | |
ML12B_HUMAN OR ML12A_HUMAN | −1.70 | 2026 | ||
ML12B_HUMAN OR ML12A_HUMAN | −1.80 | 1831 | ||
Myosin regulatory light polypeptide 9 | MYL9_HUMAN | −1.60 | 2087 | |
MYL9_HUMAN | −1.60 | 1787 | ||
MYL9_HUMAN | −1.50* | 1774 | ||
Nexilin | NEXN_HUMAN | −1.80* | 722 | |
NEXN_HUMAN | −1.90* | 2062 | ||
PDZ and LIM domain protein 1 | PDLI1_HUMAN | 1.50* | 1593 | |
Tubulin α-4A chain | TBA4A_HUMAN | 1.80 | 1806 | |
Tubulin β-1 chain | TBB1_HUMAN | 1.90* | 1088 | |
Tubulin γ-1 chain or γ-2 chain | TBG1_HUMAN OR TBG2_HUMAN | 2.00* | 1089 | |
Extracellular | Plasminogen activator inhibitor 1 | PAI1_HUMAN | −2.00* | 1973 |
Serum albumin | ALBU_HUMAN | −1.60* | 753 | |
Thrombospondin-1 | TSP1_HUMAN | 1.50* | 2072 | |
TSP1_HUMAN | 10.60* | 1516 | ||
Signaling | Annexin A4 | ANXA4_HUMAN | 1.50* | 2072 |
ANXA4_HUMAN | 2.60* | 1482 | ||
Annexin A7 | ANXA7_HUMAN | 3.00* | 1972 | |
ANXA7_HUMAN | 1.70* | 1971 | ||
Crk-like protein | CRKL_HUMAN | 1.90* | 1274 | |
Dual specificity mitogen-activated protein kinase kinase 2 | MP2K2_HUMAN | 3.00* | 1972 | |
Growth factor receptor-bound protein 2 (Grb2) | GRB2_HUMAN | 1.60* | 2081 | |
Integrin α-IIb | ITA2B_HUMAN | −1.90* | 2062 | |
ITA2B_HUMAN | 1.80* | 508 | ||
ITA2B_HUMAN | 3.00* | 492 | ||
Pleckstrin | PLEK_HUMAN | 1.80* | 2054 | |
PLEK_HUMAN | −2.00* | 1973 | ||
PLEK_HUMAN | 2.50* | 1132 | ||
PLEK_HUMAN | 1.60* | 1106 | ||
PLEK_HUMAN | 1.80* | 1105 | ||
PLEK_HUMAN | 2.10* | 1103 | ||
PLEK_HUMAN | 2.50* | 1101 | ||
PLEK_HUMAN | 2.30* | 1100 | ||
PLEK_HUMAN | 2.80* | 1099 | ||
PLEK_HUMAN | 2.50* | 1097 | ||
PLEK_HUMAN | 2.90* | 1095 | ||
PLEK_HUMAN | 3.30* | 1091 | ||
PLEK_HUMAN | 1.90* | 1088 | ||
Regulator of G-protein signaling 10 | RGS10_HUMAN | 3.00* | 2094 | |
RGS10_HUMAN | 2.90* | 1966 | ||
Regulator of G-protein signaling 18 | RGS18_HUMAN | 2.00* | 1975 | |
Rho GTPase-activating protein 17 | RHG17_HUMAN | −1.60 | 886 | |
Serine/threonine-protein kinase PAK 2 | PAK2_HUMAN | −2.90* | 842 | |
PAK2_HUMAN | −1.90* | 833 | ||
Src kinase-associated phosphoprotein 2 (SKAP-HOM) | SKAP2_HUMAN | −1.90* | 879 | |
Tyrosine-protein kinase Lck or Src or Fyn or Yes | LCK_HUMAN OR SRC_HUMAN OR | −1.60 | 886 | |
FYN_HUMAN OR YES_HUMAN | ||||
Vesicles and secretory pathway | Rab11 family-interacting protein 3 | RFIP3_HUMAN | 1.70 | 1257 |
Ras-related protein Rab-11A or Rab-11B | RB11A_HUMAN OR RB11B_HUMAN | −3.10* | 1968 | |
Ras-related protein Rab-14 | RAB14_HUMAN | −3.10* | 1968 | |
Other | 6-phosphogluconate dehydrogenase, decarboxylating | 6PGD_HUMAN | −2.00* | 1973 |
Adenosylhomocysteinase | SAHH_HUMAN | 3.00* | 1972 | |
Bridging integrator 2 | BIN2_HUMAN | 1.80* | 508 | |
BIN2_HUMAN | 3.00* | 492 | ||
Calcineurin subunit B type 1 | CANB1_HUMAN | 2.40* | 1949 | |
Calcium-binding and coiled-coil domain-containing protein | CACO1_HUMAN | 1.80* | 508 | |
1 | ||||
Clusterin | CLUS_HUMAN | 1.70 | 1257 | |
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial | ECH1_HUMAN | 2.60* | 1482 | |
Elongation factor Tu, mitochondrial | EFTU_HUMAN | −1.60* | 1974 | |
EFTU_HUMAN | −2.00* | 1973 | ||
Galectin-related protein | LEGL_HUMAN | −1.60 | 1787 | |
LEGL_HUMAN | −1.50* | 1774 | ||
Glutathione S-transferase μ 1 | GSTM1_HUMAN | −2.00* | 1654 | |
L-lactate dehydrogenase B chain | LDHB_HUMAN | 1.60* | 2081 | |
Peroxiredoxin-2 | PRDX2_HUMAN | −1.70* | 1979 | |
Peroxiredoxin-4 | PRDX4_HUMAN | 1.50* | 1593 | |
Plastin-3 | PLST_HUMAN | −1.80* | 750 | |
Protein disulfide-isomerase A3 | PDIA3_HUMAN | −1.60 | 886 | |
Protein-L-isoaspartate(D-aspartate) O-methyltransferase | PIMT_HUMAN | 1.60* | 2081 | |
Rab GDP dissociation inhibitor β | GDIB_HUMAN | 1.70* | 2063 | |
Thioredoxin-dependent peroxide reductase, mitochondrial | PRDX3_HUMAN | −3.10* | 1968 | |
PRDX3_HUMAN | 1.60* | 2081 | ||
Tripartite motif-containing protein 58 | TRI58_HUMAN | −1.60 | 886 |
Function . | Protein . | Uniprot . | Fold change . | Spot . |
---|---|---|---|---|
Cytoskeletal | Actin, cytoplasmic 1 or 2 | ACTB_HUMAN OR ACTG_HUMAN | 3.00* | 1972 |
α-centractin | ACTZ_HUMAN | 1.80* | 1105 | |
β-centractin | ACTY_HUMAN | 2.80* | 1099 | |
Caldesmon | CALD1_HUMAN | −1.60* | 753 | |
Cofilin-1 | COF1_HUMAN | −2.40* | 1969 | |
COF1_HUMAN | −2.00* | 1856 | ||
COF1_HUMAN | −2.00* | 1828 | ||
Coronin-1A | COR1A_HUMAN | −1.60 | 886 | |
Coronin-1B | COR1B_HUMAN | −1.60 | 886 | |
COR1B_HUMAN | −1.60* | 753 | ||
COR1B_HUMAN | −1.80* | 750 | ||
Dematin | DEMA_HUMAN | −2.00* | 1973 | |
Destrin | DEST_HUMAN | −1.90* | 1887 | |
Fibrinogen γ chain | FIBG_HUMAN | 1.70 | 1257 | |
Heat shock 70-kDa protein 1A/1B or 1 like | HSP71_HUMAN OR HS71L_HUMAN | −1.80* | 750 | |
Heat shock protein β-1 | HSPB1_HUMAN | 1.80 | 1674 | |
HSPB1_HUMAN | −4.10* | 1624 | ||
HSPB1_HUMAN | −2.50* | 1623 | ||
HSPB1_HUMAN | 1.80 | 1580 | ||
Microtubule-associated protein RP/EB family member 2 | MARE2_HUMAN | −1.70* | 1981 | |
Myosin regulatory light chain 12A or 12B | ML12A_HUMAN OR ML12B_HUMAN | 3.30* | 1802 | |
ML12B_HUMAN OR ML12A_HUMAN | −1.70 | 2026 | ||
ML12B_HUMAN OR ML12A_HUMAN | −1.80 | 1831 | ||
Myosin regulatory light polypeptide 9 | MYL9_HUMAN | −1.60 | 2087 | |
MYL9_HUMAN | −1.60 | 1787 | ||
MYL9_HUMAN | −1.50* | 1774 | ||
Nexilin | NEXN_HUMAN | −1.80* | 722 | |
NEXN_HUMAN | −1.90* | 2062 | ||
PDZ and LIM domain protein 1 | PDLI1_HUMAN | 1.50* | 1593 | |
Tubulin α-4A chain | TBA4A_HUMAN | 1.80 | 1806 | |
Tubulin β-1 chain | TBB1_HUMAN | 1.90* | 1088 | |
Tubulin γ-1 chain or γ-2 chain | TBG1_HUMAN OR TBG2_HUMAN | 2.00* | 1089 | |
Extracellular | Plasminogen activator inhibitor 1 | PAI1_HUMAN | −2.00* | 1973 |
Serum albumin | ALBU_HUMAN | −1.60* | 753 | |
Thrombospondin-1 | TSP1_HUMAN | 1.50* | 2072 | |
TSP1_HUMAN | 10.60* | 1516 | ||
Signaling | Annexin A4 | ANXA4_HUMAN | 1.50* | 2072 |
ANXA4_HUMAN | 2.60* | 1482 | ||
Annexin A7 | ANXA7_HUMAN | 3.00* | 1972 | |
ANXA7_HUMAN | 1.70* | 1971 | ||
Crk-like protein | CRKL_HUMAN | 1.90* | 1274 | |
Dual specificity mitogen-activated protein kinase kinase 2 | MP2K2_HUMAN | 3.00* | 1972 | |
Growth factor receptor-bound protein 2 (Grb2) | GRB2_HUMAN | 1.60* | 2081 | |
Integrin α-IIb | ITA2B_HUMAN | −1.90* | 2062 | |
ITA2B_HUMAN | 1.80* | 508 | ||
ITA2B_HUMAN | 3.00* | 492 | ||
Pleckstrin | PLEK_HUMAN | 1.80* | 2054 | |
PLEK_HUMAN | −2.00* | 1973 | ||
PLEK_HUMAN | 2.50* | 1132 | ||
PLEK_HUMAN | 1.60* | 1106 | ||
PLEK_HUMAN | 1.80* | 1105 | ||
PLEK_HUMAN | 2.10* | 1103 | ||
PLEK_HUMAN | 2.50* | 1101 | ||
PLEK_HUMAN | 2.30* | 1100 | ||
PLEK_HUMAN | 2.80* | 1099 | ||
PLEK_HUMAN | 2.50* | 1097 | ||
PLEK_HUMAN | 2.90* | 1095 | ||
PLEK_HUMAN | 3.30* | 1091 | ||
PLEK_HUMAN | 1.90* | 1088 | ||
Regulator of G-protein signaling 10 | RGS10_HUMAN | 3.00* | 2094 | |
RGS10_HUMAN | 2.90* | 1966 | ||
Regulator of G-protein signaling 18 | RGS18_HUMAN | 2.00* | 1975 | |
Rho GTPase-activating protein 17 | RHG17_HUMAN | −1.60 | 886 | |
Serine/threonine-protein kinase PAK 2 | PAK2_HUMAN | −2.90* | 842 | |
PAK2_HUMAN | −1.90* | 833 | ||
Src kinase-associated phosphoprotein 2 (SKAP-HOM) | SKAP2_HUMAN | −1.90* | 879 | |
Tyrosine-protein kinase Lck or Src or Fyn or Yes | LCK_HUMAN OR SRC_HUMAN OR | −1.60 | 886 | |
FYN_HUMAN OR YES_HUMAN | ||||
Vesicles and secretory pathway | Rab11 family-interacting protein 3 | RFIP3_HUMAN | 1.70 | 1257 |
Ras-related protein Rab-11A or Rab-11B | RB11A_HUMAN OR RB11B_HUMAN | −3.10* | 1968 | |
Ras-related protein Rab-14 | RAB14_HUMAN | −3.10* | 1968 | |
Other | 6-phosphogluconate dehydrogenase, decarboxylating | 6PGD_HUMAN | −2.00* | 1973 |
Adenosylhomocysteinase | SAHH_HUMAN | 3.00* | 1972 | |
Bridging integrator 2 | BIN2_HUMAN | 1.80* | 508 | |
BIN2_HUMAN | 3.00* | 492 | ||
Calcineurin subunit B type 1 | CANB1_HUMAN | 2.40* | 1949 | |
Calcium-binding and coiled-coil domain-containing protein | CACO1_HUMAN | 1.80* | 508 | |
1 | ||||
Clusterin | CLUS_HUMAN | 1.70 | 1257 | |
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial | ECH1_HUMAN | 2.60* | 1482 | |
Elongation factor Tu, mitochondrial | EFTU_HUMAN | −1.60* | 1974 | |
EFTU_HUMAN | −2.00* | 1973 | ||
Galectin-related protein | LEGL_HUMAN | −1.60 | 1787 | |
LEGL_HUMAN | −1.50* | 1774 | ||
Glutathione S-transferase μ 1 | GSTM1_HUMAN | −2.00* | 1654 | |
L-lactate dehydrogenase B chain | LDHB_HUMAN | 1.60* | 2081 | |
Peroxiredoxin-2 | PRDX2_HUMAN | −1.70* | 1979 | |
Peroxiredoxin-4 | PRDX4_HUMAN | 1.50* | 1593 | |
Plastin-3 | PLST_HUMAN | −1.80* | 750 | |
Protein disulfide-isomerase A3 | PDIA3_HUMAN | −1.60 | 886 | |
Protein-L-isoaspartate(D-aspartate) O-methyltransferase | PIMT_HUMAN | 1.60* | 2081 | |
Rab GDP dissociation inhibitor β | GDIB_HUMAN | 1.70* | 2063 | |
Thioredoxin-dependent peroxide reductase, mitochondrial | PRDX3_HUMAN | −3.10* | 1968 | |
PRDX3_HUMAN | 1.60* | 2081 | ||
Tripartite motif-containing protein 58 | TRI58_HUMAN | −1.60 | 886 |
A negative fold change indicates that the protein feature is up-regulated in basal (unstimulated) platelets, whereas a positive fold change indicates that the spot is up-regulated in rhodocytin-stimulated platelets. Differentially regulated features have a fold change ≥ 1.5 and a P value < .05
P < .01.